Home » Prices » NASDAQ:ZNTL

Zentalis Pharmaceuticals Inc. NASDAQ:ZNTL

Today's live share price, quote history, chart & news

Price:
42.65 USD
Change:
-1.44 (-3.27%)
Key Stats
Price open 43.62
Previous close 44.09
Market cap 1.53B
Volume 107.41K
Day high 43.92
Day low 42.08
Year high 59.32
Year low 22
Year to date change 103.50%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin Bunker on December 23, 2014 and is headquartered in New York, NY.

Company information

Company name
Zentalis Pharmaceuticals, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
62
CEO
Anthony Y. Sun
Address
530 Seventh Avenue, New York, NY, 10018
Country
United States
Contact information
1.212.433.3791
Website
http://www.zentalis.com
Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.